Cresco Labs (CRLBF) Other Non-Current Liabilities (2020 - 2026)

Cresco Labs has reported Other Non-Current Liabilities for 7 years, with the latest figure at $184.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 36.15% year-over-year to $184.9 million; the trailing twelve-month figure through Mar 2026 stood at $184.9 million (up 36.15% YoY), and the FY2025 full-year result was $171.5 million, up 2005.01% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $184.9 million, up from $171.5 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $184.9 million in Q1 2026, with the low at $7.0 million in Q3 2022.
• Historically, Other Non-Current Liabilities has averaged $64.9 million across 5 years, with a median of $16.6 million in 2022.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities slumped 59.7% — and 2025, when it surged 2048.0%.
• Cresco Labs' Other Non-Current Liabilities stood at $12.9 million in 2022, then surged by 56.67% to $20.2 million in 2023, then tumbled by 59.7% to $8.1 million in 2024, then surged by 2005.01% to $171.5 million in 2025, then gained by 7.83% to $184.9 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $184.9 million (Q1 2026), $171.5 million (Q4 2025), and $165.2 million (Q3 2025), per Business Quant data.